This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Stocks to Watch: Apple, Foot Locker

Stocks in this article: AAPL FL BRCD ARO GPS MRVL SJM WAG

Marvell Technology (MRVL):

The Santa Clara, Calif.-based chip maker reported adjusted earnings of $142 million, or 24 cents a share, in its fiscal second quarter on revenue of $816.1 million, missing the average estimate of analysts polled by Thomson Reuters for a profit of 26 cents a share on revenue of $852.7 million.

Marvell said its performance was held back by the weak macro-economic environment, which hurt its storage and mobile end markets.

Shares of Marvell closed Thursday at $12.28, and fell nearly 9% in after-hours action.

J.M. Smucker (SJM):

The Orrville, Ohio-based food products company reported adjusted earnings of $129.3 million, or $1.17 a share, for its fiscal first quarter ended in July on revenue of $1.37 billion. The average estimate of analysts polled by Thomson Reuters was for a profit of $1 per share on revenue of $1.30 billion.

"We are pleased with the solid start to the fiscal year with growth in volume, sales, and cash flow," said Richard Smucker, the company's CEO, in a press release. "While the environment remains challenging, we continue to drive long-term growth through brand-building, product innovation, acquisitions, and productivity initiatives while maintaining a healthy balance between volume, market share, and profitability. Our results demonstrate the strength and resiliency of our iconic brands, our ability to adjust rapidly in the marketplace, and the commitment of our team to our strategy."

For fiscal 2013, J.M. Smucker backed its forecast for non-GAAP earnings of $5 to $5.10 a share with sales expected to rise 7%, and said it sees earnings at the top end of its projected range based on current expectations.

Walgreens (WAG):

Morgan Stanley upgraded the drugstore operator to equal-weight from underweight and removed its $31 price target.

"Express Scripts overhang removed, but risks remain: The resolution of the Express Scripts dispute removes the risk of further script losses and opens the door for Walgreens to start winning back lost customers," the firm said. "However, investors must now contemplate 1) the level of couponing required to lure back customers; 2) lingering front-end weakness from lost Express customer traffic; 3) margins under the new Express-Medco contract; and 4) risk that the Express-related cost cutting may have affected service levels for other customers."

The stock closed Thursday at $35.52, up more than 3% in the past year.

-- Written by Michael Baron in New York.

>To contact the writer of this article, click here: Michael Baron.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.
2 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,778.15 +421.28 2.43%
S&P 500 2,057.40 +44.51 2.21%
NASDAQ 4,743.2230 +98.9110 2.13%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs